Activités à venir

Cardiovascular Innovations (CVI) 2019 is a world-class meeting focused on state-of-the-art therapy for peripheral, coronary, and structural heart disease. More than 180 faculty are confirmed and will present during the 4-day meeting. The conference is designed to meet the needs of cardiologists, surgeons, physicians, trainees, investigators, and allied health care staff, who participate in the care of these patients. The focus of the conference is on innovative health care solutions to optimize the delivery of care for these patients.

The goal of the 2019 CICT Conference is to promote high quality, patient-centered, clinical and technical decision-making in the field of Interventional Cardiovascular Medicine. The uniqueness of the CICT conference lies in the open forum transparent discussion of controversial topics allowing free-flowing interaction between audience and faculty. The content of this meeting will address a wide range of complex cardiovascular interventional topics that still present a challenge to the clinician with respect to choosing the appropriate therapy (surgery vs. catheter-based therapy) and with respect to using optimal technique to ensure the safety and efficacy of the procedure.

The 2019 Appalachian Structural Heart Symposium (ASHS|19) conference will provide a comprehensive review of current topics, treatments, and strategies for Structural Heart Disease including: transcatheter aortic valve replacement (TAVR), cardiogenic shock, imaging techniques, medications, case presentations, and poster sessions. This interdisciplinary conference is designed for physicians, pharmacists, nurses, radiologic technicians and technologists, and all interested allied health professionals. On Saturday afternoon there will be concurrent breakout sessions; one for physicians and a simultaneous program for nurses and radiologic technologists and technicians.

Focusing on the latest interventional catheter strategies for congenital and structural heart disease in children and adults. Once again we are fully committed to ensuring the meeting maintains its clinical focus with the addition of taped cases to sessions on both congenital and structural heart disease, as well as live case demonstrations from around the globe.

This program is designed to meet the continuing education (CE) needs of cardiologists, electrophysiologists, primary care physicians, advanced practice providers, and allied health professionals who care for arrhythmia patients. The overall goal of the activities is to enhance learners' knowledge and their competency to incorporate evidence-based updates in their practice. The symposium will focus on the collaborative care of patients with heart rhythm disorders and will offer sessions specifically for advanced cardiology, primary care, and advanced practice providers.

This program is designed to provide electrophysiologists, cardiologists, internists, and associated professionals with state-of-the-art information on invasive and non-invasive electrocardiographic and electrophysiologic tools used in the diagnosis, evaluation, and treatment of cardiac rhythm disorders. Attendees of the symposium will develop an understanding of the best practice approaches to diagnosing and treating patients with atrial fibrillation, other atrial and ventricular tachycardias, and risk factors of sudden death.

The scientific sessions will focus on management of atrial fibrillation, ventricular arrhythmias and sudden death, device management, as well as innovations in device and ablation therapy. The faculty will include internationally recognized leaders in electrophysiology from University of Colorado, Virginia Commonwealth University, University of Pennsylvania, Texas Cardiac Arrhythmia Institute, University of Pennsylvania, and Harvard Medical School.

This one-day program is designed to review selected topics in present-day management of patients with structural diseases, emphasizing new innovation in the field, the role of imaging in clinical practice and guidance for structural heart interventions, and the incorporation of current guideline and evidence-based principles of practice. Expert faculty will discuss patient selection, screening, and management of mitral, aortic, and tricuspid valve disease, left atrial appendage closure, and patent foramen ovale atrial septal defect closure.

Attend Heart of the Future 2019 and learn from our physicians who are innovators in the fields of invasive cardiovascular intervention.

This is an opportunity to hear about the current therapies and treatment options for Pediatric and Adult Congenital Heart patients.

Lectures will focus on patient care from fundamental principles to cutting edge therapies.

As discoverers in a new era of cardiovascular medicine, the Cardiovascular Division is focused on solving complex issues that require revolutionary approaches and endless creativity. Our team says yes when others say it can’t be done. And our team says yes to bold ideas, creativity, innovation, and results.

Your participation at Red Heart Soirée helps support cardiovascular research, education, and patient care to get us closer to achieving the ultimate goal of curing heart disease.

This one-day symposium provides a comprehensive update on the long-term issues faced by adult Fontan survivors. The course focuses on patients with “failing” Fontan physiology and the available tools and therapies for the treatment of this challenging subset of patients, including updates on medical therapies, catheter-based and surgical techniques for palliation and support. The ultimate therapeutic options of orthotopic heart and multi-organ transplantation are covered in detail as the need grows in this aging Fontan population. The target audience includes adult and pediatric congenital cardiologists, congenital and transplant cardiac surgeons, heart failure/transplant specialists, hepatologists, liver transplant surgeons, cardiac intensivists, cardiology and cardiac surgery trainees, cardiac nurses, nurse practitioners, and physician assistants.

Rassemblée sur 5 demi-journées, cette manifestation aborde l’essentiel des thèmes de la stimulation, de la défibrillation et de la rythmologie à la fois en séances plénières et en ateliers pratiques.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Now in its 31st year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.

This 1.5-day symposium will provide an opportunity for leaders in electrophysiology (EP) research and clinical practice to interact in a forum which will encourage an open discussion of research, challenges, and future directions in EP. The prestigious international faculty will focus on global issues and the latest EP developments, encouraging innovation and collaboration. Discussions on current changes in the healthcare environment and how these changes affect clinical practice will be included.